| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf2a3a767ae32dfcda1f4e6642aeadc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4afb8b01aa8de7e0b24a86713b23a18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f48e2ccd837d231633896ba01f22823d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6db9d99be1d2e169a472740488172e2d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2011-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75b12e6a70e85d6b877f3ac263ad7327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a5fb3231eb12e0a6fb09c812b7b3f6f |
| publicationDate |
2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012034955-A1 |
| titleOfInvention |
Treatment of bacterial infectious diseases |
| abstract |
The present invention relates to a novel pharmacological treatment of bacterial infectious diseases in humans. Specifically the invention relates to the use of apramycin of formula (I) or apramycin derivatives to treat bacterial infectious diseases in humans. It is demonstrated that apramycin surprisingly does not have the expected high level of toxicity observed with related aminoglycoside antibiotics but actually is even significantly less toxic than compounds already used in human medicine such as gentamicin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135234-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2549485-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016300993-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2611391-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2751634-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3498723-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617704-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2526121-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3330275-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I699372-B |
| priorityDate |
2010-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |